Idera Pharmaceuticals announces termination of merger agreement with BioCryst
BioCryst Pharmaceuticals announced it has terminated the previously announced merger agreement with Idera Pharmaceuticals following the BioCryst stockholders’ failure to approve the adoption of the merger agreement at the BioCryst Special Meeting of Stockholders. July 13, 2018